SP-100030
目录号: PL07785 纯度: ≥99%
CAS No. :154563-54-9
商品编号 规格 价格 会员价 是否有货 数量
PL07785-5mg 5mg ¥2250.00 请登录
PL07785-10mg 10mg ¥3536.00 请登录
PL07785-25mg 25mg ¥9482.00 请登录
PL07785-50mg 50mg ¥14786.00 请登录
PL07785-100mg 100mg ¥24109.00 请登录
PL07785-200mg 200mg 询价 询价
PL07785-500mg 500mg 询价 询价
PL07785-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2475.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
SP-100030
中文别名
SP 100030
英文名称
SP-100030
英文别名
SP 100030;N-[3,5-Bis(trifluoromethyl)phenyl]-2-chloro-4-(trifluoromethyl)-5-pyrimidinecarboxamide;sp100030;BDBM50062648;N-(3,5-Bis(trifluoromethyl)phenyl)-2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxamide;2-Chloro-4-trifluoromethyl-pyrimidine-5-carboxylic acid (3,5-bis-trifluoromethyl-phenyl)-amide;N-[3,5-Bis(trifluoromethyl)phenyl]-2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxamide;SP-100030
Cas No.
154563-54-9
分子式
C14H5ClF9N3O
分子量
437.65
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
SP-100030 是一种有效的 NF-κB 和激活蛋白-1 (AP-1) 双抑制剂 (IC50 分别为 50 和 50 nM)。SP-10003 抑制 Jurkat和其他T细胞系产生的 IL-2、IL-8 和 TNF-α 的产生。SP-100030 降低小鼠胶原性关节炎 (CIA)。
生物活性
SP-100030 is a potent NF-κB and activator protein-1 (AP-1) double inhibitor (IC 50 s=50 and 50 nM, respectively). SP-100030 inhibits IL-2, IL-8, and TNF-alpha production in Jurkat and other T cell lines. SP-100030 decreases murine collagen-induced arthritis (CIA).
性状
Solid
体外研究(In Vitro)
SP-100030 blocks the production of IL-2 and IL-8 in Jurkat T-cells at the same concentrations as seen in the luciferase assay (IC50≈30 nM).
ELISA and RT-PCR confirmed that IL-2, IL-8, and TNF-alpha production by activated Jurkat and other T cell lines were inhibited by SP100030. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
SP100030 (10 mg/kg/day; i.p.; day 21 to day 34) significantly decreased arthritis severity. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Six- to 8-wk-old male DBA/1J mice (immunize
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Sullivan RW, et al. 2-Chloro-4-(trifluoromethyl)pyrimidine-5-N-(3,5- bis(trifluoromethyl)phenyl)-carboxamide: a potent inhibitor of NF-kappa B- and AP-1-mediated gene expression identified using solution-phase combinatorial chemistry. J Med Chem. 1998;4
[2]. Gerlag DM, et al. The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis. J Immunol. 2000;165(3):1652-1658.
溶解度数据
In Vitro: DMSO : 50 mg/mL (114.25 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2